Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents
Yuan Zhang,Lu Luo,Chao Han,Handeng Lv,Di Chen,Guoliang Shen,Kaiqi Wu,Suwei Pan,Faqing Ye
DOI: https://doi.org/10.3390/molecules22111960
IF: 4.6
2017-11-13
Molecules
Abstract:We designed and synthesized 26 prototype compounds and studied their anti-inflammatory activity and underlying molecular mechanisms. The inhibitory effects of the compounds on the production of nitric oxide (NO), cytokines, inflammatory-related proteins, and mRNAs in lipopolysaccharide (LPS)-stimulated macrophages were determined by the Griess assay, Enzyme linked immunosorbent assay (ELISA), Western blot analysis, and Reverse transcription-Polymerase Chain Reaction (RT-PCR), respectively. Our results indicated that treatment with <b>A2</b>, <b>A6</b> and <b>B7</b> significantly inhibited the secretion of NO and inflammatory cytokines in RAW264.7 cells without demonstrable cytotoxicity. It was also found that <b>A2</b>, <b>A6</b> and <b>B7</b> strongly suppressed the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase enzyme COX-2, and prevented nuclear translocation of nuclear factor κB (NF-κB) p65 by inhibiting the degradation of p50 and IκBα. Furthermore, the phosphorylation of mitogen-activated protein kinase (MAPKs) in LPS-stimulated RAW264.7 cells was significantly inhibited by <b>A2</b>, <b>A6</b> and <b>B7</b>. These findings suggest that <b>A2</b>, <b>A6</b> and <b>B7</b> may operate as an effective anti-inflammatory agent through inhibiting the activation of NF-κB and MAPK signaling pathways in macrophages. Moreover, rat paw swelling experiments showed that these compounds possess anti-inflammatory activity in vivo, with compound <b>A6</b> exhibiting similar activities to the reference drug Indomethacin.
chemistry, multidisciplinary,biochemistry & molecular biology